Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Morton S. Kahlenberg"'
Autor:
Frank A. Sinicrope, Qian Shi, Aurelie Catteau, Graham M. Poage, Tyler J. Zemla, Bernhard Mlecnik, Al B. Benson, Sharlene Gill, Richard M. Goldberg, Morton S. Kahlenberg, Suresh G. Nair, Anthony F. Shields, Thomas C. Smyrk, Jerome Galon, Steven R. Alberts
Publikováno v:
JCO Precision Oncology.
PURPOSE The recommended duration of adjuvant fluoropyrimidine and oxaliplatin chemotherapy for patients with stage III colon cancer is based on tumor classification into clinically low-risk (T1-3 N1) and high-risk (T4 or N2) groups. We determined whe
Autor:
Thomas C. Smyrk, Sharlene Gill, Suresh G. Nair Md, Steven J. Cohen, Sawyer B. Jacobson, Anthony F. Shield, Morton S. Kahlenberg, Balkrishna N. Jahagirdar, Nathan R. Foster, Richard M. Goldberg, Steven R. Alberts, Michael Pollak, Qian Shi, Frank A. Sinicrope
Publikováno v:
JNCI Cancer Spectrum
Background Adipocyte-derived adiponectin may play a role in the host inflammatory response to cancer. We examined the association of plasma adiponectin with the density of tumor-infiltrating lymphocytes (TILs) in colon cancers and with vitamin D, cli
Autor:
Suresh G. Nair Md, Morton S. Kahlenberg, Al B. Benson, Fabienne Hermitte, Anthony F. Shields, Jérôme Galon, Thomas C. Smyrk, Tyler J Zemla, Frank A. Sinicrope, Steven R. Alberts, Qian Shi, Richard M. Goldberg, Sharlene Gill, Bernhard Mlecnik
Publikováno v:
JNCI Cancer Spectrum
Background The American Joint Committee on Cancer staging and other prognostic tools fail to account for stage-independent variability in outcome. We developed a prognostic classifier adding Immunoscore to clinicopathological and molecular features i
Autor:
Thomas C. Smyrk, Frank A. Sinicrope, Richard M. Goldberg, Sawyer B. Jacobson, Qian Shi, Michael Pollak, Suresh G. Nair Md, Steven R. Alberts, Nathan R. Foster, Balkrishna N. Jahagirdar, Morton S. Kahlenberg, Steven J. Cohen, Sharlene Gill, Anthony F. Shields
Publikováno v:
Journal of Clinical Oncology. 39:3591-3591
3591 Background: Adiponectin is a peptide hormone exclusively secreted by adipocytes that plays a role in immune regulation and in the host inflammatory response to cancer. We examined postsurgical adiponectin levels in relationship to tumor infiltra
Autor:
Frank A. Sinicrope, Steven R. Alberts, Sharlene Gill, Preet Paul Singh, Suresh G. Nair Md, Qian Shi, Nathan R. Foster, Anthony F. Shields, Morton S. Kahlenberg, Richard M. Goldberg, Daniel J. Sargent, Emily Chan, Axel Grothey
Publikováno v:
The Oncologist
Metformin might have antineoplastic properties against colon cancer (CC). Patients with stage III CC enrolled in the N0147 study completed a questionnaire regarding diabetes mellitus (DM) and metformin use. Patients with stage III CC undergoing adjuv
Autor:
Steven R. Alberts, Amanda I. Phipps, Paul J. Limburg, Richard M. Goldberg, Anthony F. Shields, Polly A. Newcomb, Garth D. Nelson, Daniel J. Sargent, Morton S. Kahlenberg, Qian Shi, Frank A. Sinicrope, Suresh G. Nair Md, Sharlene Gill, Emily Chan
Publikováno v:
International Journal of Cancer. 139:986-995
Alcohol consumption is associated with a modest increased risk of colon cancer, but its relationship with colon cancer survival has not been elucidated. Using data from a phase III randomized adjuvant trial, we assessed the association of alcohol con
Autor:
Suresh G. Nair Md, Emily Chan, Robert B. Diasio, Richard M. Goldberg, Jeffrey L. Berenberg, Anthony F. Shields, Sharlene Gill, Morton S. Kahlenberg, Blase N. Polite, Adam M. Lee, Steven R. Alberts, Daniel J. Sargent, Qian Shi, Axel Grothey, Frank A. Sinicrope
Severe (gradeâ¥3) adverse events (AEs) to 5-fluorouracil (5-FU)-based chemotherapy regimens can result in treatment delays or cessation, and, in extreme cases, life-threatening complications. Current genetic biomarkers for 5-FU toxicity predictio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a12ccb7a9978f247cce8eb8ac62a86
https://europepmc.org/articles/PMC4738010/
https://europepmc.org/articles/PMC4738010/
Autor:
Mark G. Kris, Steven I. Benowitz, Sylvia Adams, Lisa Diller, Patricia Ganz, Morton S. Kahlenberg, Quynh-Thu Le, Maurie Markman, Greg A. Masters, Lisa Newman, Jennifer C. Obel, Andrew D. Seidman, Sonali M. Smith, Nicholas Vogelzang, Nicholas J. Petrelli
Publikováno v:
Journal of Clinical Oncology. 28:5327-5347
A MESSAGE FROM ASCO'S PRESIDENT Like many health professionals who care for people with cancer, I entered the field because of specific patients who touched my heart. They still do. In an effort to weave together my personal view of what the American
Autor:
Richard M. Goldberg, Frank A. Sinicrope, Qian Shi, Al B. Benson, Erica N. Heying, Suresh G. Nair Md, Fabienne Hermitte, Morton S. Kahlenberg, Jérôme Galon, Anthony F. Shields, Daniel J. Sargent, Steven R. Alberts, Sharlene Gill
Publikováno v:
Journal of Clinical Oncology. 36:614-614
614 Background: A consensus interpretation of the IDEA colon cancer study results suggested that risk categories based on T/N stage grouping be used to guide decision-making for duration (3 vs 6 months) of adjuvant FOLFOX or CapeOX chemotherapy. Give
Autor:
Nicholas J. Petrelli, Luis Baez-Diaz, Melvin Deutsch, Mark S. Roh, Michael J. O'Connell, Linda H. Colangelo, Carmen J. Allegra, Greg Yothers, Carol S. Ursiny, Norman Wolmark, Morton S. Kahlenberg
Publikováno v:
Journal of Clinical Oncology. 27:5124-5130
Purpose Although chemoradiotherapy plus resection is considered standard treatment for operable rectal carcinoma, the optimal time to administer this therapy is not clear. The NSABP R-03 (National Surgical Adjuvant Breast and Bowel Project R-03) tria